Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Martin Štork"'
Autor:
Monika Vlachová, Lukáš Pečinka, Jana Gregorová, Lukáš Moráň, Tereza Růžičková, Petra Kovačovicová, Martina Almáši, Luděk Pour, Martin Štork, Roman Hájek, Tomáš Jelínek, Tereza Popková, Marek Večeřa, Josef Havel, Petr Vaňhara, Sabina Ševčíková
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Multiple myeloma (MM) is the second most prevalent hematological malignancy, characterized by infiltration of the bone marrow by malignant plasma cells. Extramedullary disease (EMD) represents a more aggressive condition involving the migrat
Externí odkaz:
https://doaj.org/article/123756e52c444a3ba9395eee02fa6b55
Publikováno v:
Molecular Cytogenetics, Vol 11, Iss 1, Pp 1-6 (2018)
Abstract Background Catastrophic chromosomal event known as chromothripsis was proven to be a significant hallmark of poor prognosis in several cancer diseases. While this phenomenon is very rare in among multiple myeloma (MM) patients, its presence
Externí odkaz:
https://doaj.org/article/453fdb67fa154f95a42da5e2571514d9
Autor:
Romana Bútová, Petra Vychytilová-Faltejsková, Jana Gregorová, Lenka Radová, Martina Almáši, Renata Bezděková, Lucie Brožová, Jiří Jarkovský, Zdeňka Knechtová, Martin Štork, Luděk Pour, Sabina Ševčíková
Publikováno v:
Biomedicines, Vol 9, Iss 11, p 1637 (2021)
Long non-coding RNAs (lncRNAs) are functional RNAs longer than 200 nucleotides. Due to modern genomic techniques, the involvement of lncRNAs in tumorigenesis has been revealed; however, information concerning lncRNA interplay in multiple myeloma (MM)
Externí odkaz:
https://doaj.org/article/f43e6c946a264e1f92f59c50de106207
Autor:
Zdeněk Adam, David Zeman, Luděk Pour, Marta Krejčí, Martin Krejčí, Zdeněk Řehák, Renata Koukalová, Viera Sandecká, Martin Štork, Gabriela Romanová, Zuzana Adamová, Zdeněk Král
Publikováno v:
Onkologie. 16:83-102
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::56741b2a5414ffd033c1b5644a8cdaab
https://doi.org/10.36290/xon.2022.058
https://doi.org/10.36290/xon.2022.058
Autor:
Martin Štork
Publikováno v:
Klinicka onkologie. 36
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::398cb1facebef65db8e9eee8bc56180a
https://doi.org/10.48095/ccko2023150
https://doi.org/10.48095/ccko2023150
Autor:
Zdeněk Adam, Zdeněk Řehák, Zuzana Adamová, Renata Koukalová, Luděk Pour, Marta Krejčí, Ivanna Boichuk, Viera Sandecká, Martin Krejčí, Martin Štork, Sabina Ševčíková, Zdeněk Král
Publikováno v:
Vnitřní lékařství. 68:41-53
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5cc9bb96db84e60153ef5530e213623e
https://doi.org/10.36290/vnl.2022.006
https://doi.org/10.36290/vnl.2022.006
Autor:
Zdeněk Adam, Milan Dastych, Aleš Čermák, Martina Doubková, Šárka Skorkovská, Luděk Pour, Zdeněk Řehák, Renata Koukalová, Zuzana Adamová, Martin Štork, Marta Krejčí, Ivanna Boichuk, Zdeněk Král
Publikováno v:
Vnitrni lekarstvi. 68(E-6)
Immunoglobulin IgG4 related disease (IgG4-RD) is a heterogeneous disorder with multi-organ involvement recognised as a separate entity at the beginning of this century only. Evolving therapy is reviewed in this paper. Glucocorticoids are first choice
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23912eafc764499afb1e3ea0174173c1
https://pubmed.ncbi.nlm.nih.gov/36316207
https://pubmed.ncbi.nlm.nih.gov/36316207
Autor:
Zdeněk Adam, Luděk Pour, Miroslav Tomíška, Karel Starý, Teodor Horváth, Martina Doubková, Tomáš Nebeský, Zdeněk Řehák, Renata Koukalová, Marta Krejčí, Martin Krejčí, Ivanna Boichuk, Martin Štork, Sabina Ševčíková, Zuzana Adamová, Zdeněk Král
Publikováno v:
Vnitrni lekarstvi. 68(E-2)
Langerhans cell histiocytosis (LCH) is a rare condition with incidence in adults 1-2/1 million, wherein Langerhans cells proliferate abnormally, adversely impacting organs including most frequently bones, skin, lungs, pituitary gland, lymph nodes, gu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45b490f2411b94ba9da0b25d9f9e6b6e
https://pubmed.ncbi.nlm.nih.gov/36208940
https://pubmed.ncbi.nlm.nih.gov/36208940
Autor:
Zdeněk Adam, Zdeněk Řehák, Zuzana Adamová, Luděk Pour, Klára Dvořáková, Barbora Packová, Renata Koukalová, Martin Krejčí, Marta Krejčí, Martin Štork, Viera Sandecká, Ivanna Boichuk, Zdeněk Král
Publikováno v:
Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti. 35(4)
Lenalidomid ranks among immunomodulatory drugs. There are a few of the more common side effects, like a higher risk of venous trombembolism or diarrhea. Other side effects are rare. The hyperbilirubinemia described in this article can be assigned to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e43b1daf11479ed71903aa455c714351
https://pubmed.ncbi.nlm.nih.gov/35989089
https://pubmed.ncbi.nlm.nih.gov/35989089
Autor:
Viera SANDECKA, Luděk POUR, Ivan ŠPIČKA, Jiří MINAŘÍK, Jakub RADOCHA, Tomáš JELÍNEK, Petr PAVLÍČEK, Alexandra JUNGOVÁ, Petr KESSLER, Marek WRÓBEL, Martin ŠTORK, Jan ŠTRAUB, Tomáš PIKA, Lenka ČÁPKOVÁ, Sabina ŠEVČÍKOVÁ, Vladimír MAISNAR, Roman HÁJEK
Publikováno v:
Neoplasma. 69(6)
We assessed the outcomes of pomalidomide and dexamethasone treatment in relapsed/refractory multiple myeloma (RRMM) patients with ≥1 prior line of therapy. We analyzed the data of all RRMM patients treated with pomalidomide and dexamethasone at nin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0549b45be2adbb252d16072e7e0e3d59
https://pubmed.ncbi.nlm.nih.gov/36591805
https://pubmed.ncbi.nlm.nih.gov/36591805